Big pharma stocks like Johnson & Johnson (NYSE:JNJ) and Pfizer (NYSE:PFE) have long been favorites of dividend growth investors and for good reason. Their recession resistant business models and steady cash flows allow for generous, secure, and steadily growing payouts that generally result in solid market beating long-term performance.
JNJ Total Return Price data by YCharts
Of course, thanks to historically low interest rates since the financial crisis, blue chip dividend growth stocks like these have seen massive extra interest from yield starved investors clamoring for quality bond alternatives.
